Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1994-7-21
|
pubmed:abstractText |
Fine needle aspirates (FNA) from 106 high-risk women and 25 low-risk women were evaluated for overexpression of estrogen receptor (ER), epidermal growth factor receptor (EGFR), mutant p53, and HER-2/neu by immunocytochemistry, and for aneuploidy by image analysis. Aspirates were also classified cytologically as normal, apocrine metaplasia, epithelial hyperplasia (EH), or dysplasia. High-risk women were those with a first-degree relative with breast cancer (76%), precancerous breast disease (26%), prior cancer of the contralateral breast (9%), or multiple abnormalities (11%). Low-risk women had none of the above risk factors, nor a prior breast biopsy or clinical evidence of fibrocystic disease. The median 10-year Gail risk for the high-risk group was 4%, compared to 0.7% for the low-risk group. There were significant differences (p < 0.01) between high- and low-risk women in the prevalences of hyperplasia (55% versus 12%), dysplasia (19% versus 0%), aneuploidy (32% versus 0%), overexpressed EGFR (32% versus 4%), and overexpressed p53 (29% versus 4%). The prevalence of multiple biomarker abnormalities was also greater in high-risk than in low-risk women (28% versus 0%; p < 0.01). Four percent (4%) of FNAs from high-risk women with normal cytology, 29% of aspirates with hyperplastic cytology, and 60% of those with dysplasia were associated with two or more biomarker abnormalities. The differences in the prevalence of multiple biomarker abnormalities among various cytologic categories were statistically significant (p = 0.02, normal versus EH; p = 0.02, EH versus dysplasia; p < 0.01, normal versus dysplasia).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0733-1959
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17G
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
153-60
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:7911861-Biopsy, Needle,
pubmed-meshheading:7911861-Breast Neoplasms,
pubmed-meshheading:7911861-Female,
pubmed-meshheading:7911861-Genes, p53,
pubmed-meshheading:7911861-Humans,
pubmed-meshheading:7911861-Image Processing, Computer-Assisted,
pubmed-meshheading:7911861-Middle Aged,
pubmed-meshheading:7911861-Pilot Projects,
pubmed-meshheading:7911861-Ploidies,
pubmed-meshheading:7911861-Proto-Oncogene Proteins,
pubmed-meshheading:7911861-Receptor, Epidermal Growth Factor,
pubmed-meshheading:7911861-Receptor, erbB-2,
pubmed-meshheading:7911861-Receptors, Estrogen,
pubmed-meshheading:7911861-Risk Factors,
pubmed-meshheading:7911861-Tumor Markers, Biological
|
pubmed:year |
1993
|
pubmed:articleTitle |
Biomarker and cytologic abnormalities in women at high and low risk for breast cancer.
|
pubmed:affiliation |
University of Kansas Cancer Center, Kansas City 66160.
|
pubmed:publicationType |
Journal Article
|